Premier Indian technical university acting as the Indo-European research bridge for EU projects in vaccines, wastewater treatment, and hydrogen combustion.
IIT Madras is one of India's premier technical universities, running research groups across engineering, life sciences, and environmental technology. Their H2020 footprint shows them acting as the Indian scientific partner in EU consortia on three very different fronts: clean combustion for gas turbines and boilers, decentralized wastewater treatment suited to Indian conditions, and next-generation influenza vaccine development. They bring Indian field data, local regulatory context, and research capacity — which is exactly what EU projects need when they want solutions validated outside Europe.
Saraswati 2.0 focused on identifying best available technologies for decentralized wastewater treatment, with IITM contributing on affordability, regulations and social acceptance in the Indian context.
INCENTIVE is an Indo-European consortium on next-generation influenza vaccines covering preclinical validation, human trials and immune profiling.
POLKA trained researchers on hydrogen combustion, thermoacoustic instability and flame flashback for decarbonised gas turbines and boilers.
Both Saraswati 2.0 and INCENTIVE are explicitly Indo-European collaborations with technology transfer and data integration as stated aims.
With only three H2020 projects, all starting between 2019 and 2020, there isn't a long internal timeline to compare — the organization's EU engagement is recent rather than evolutionary. Across this short window the direction shifted from clean-energy combustion research (POLKA, 2019) toward health and environmental sciences applied to Indian contexts (Saraswati 2.0, INCENTIVE). The common thread across all three is their role as the Indian anchor partner in bilateral Indo-EU consortia.
They appear to be positioning themselves as the go-to Indian academic partner for EU projects that need real-world validation in emerging-market conditions, particularly in health and environmental technology.
IITM has never coordinated a H2020 project — they join as a partner or third party, contributing domain expertise and local access rather than running the show. They operate inside fairly large consortia: 51 unique partners across 17 countries in just three projects suggests each consortium is broad and international. They are a specialist contributor who plugs into EU-led networks rather than a hub that convenes its own.
51 partners across 17 countries from only three projects — a very wide network per project. Their collaborations are explicitly Indo-European, with Europe as the center of gravity and IITM as the Indian node.
IITM is one of very few Indian institutions that appears repeatedly in H2020 consortia, which gives them a rare profile as a trusted Indo-European research bridge. For a coordinator who needs Indian field sites, Indian regulatory knowledge, or access to the Indian market for a technology developed in Europe, IITM is a natural first call. Their spread across combustion, water, and vaccines also signals a large, multidisciplinary institute rather than a single-domain lab.
